SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-12-004216
Filing Date
2012-08-14
Accepted
2012-08-14 16:12:28
Documents
5
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT slxcf_10q.htm 10-Q 686478
2 CETIFICATION slxcf_ex311.htm EX-31.1 15593
3 CETIFICATION slxcf_ex312.htm EX-31.2 16047
4 CETIFICATION slxcf_ex321.htm EX-32.1 6624
5 CETIFICATION slxcf_ex322.htm EX-32.2 7406
  Complete submission text file 0001354488-12-004216.txt   733186
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
STELLAR PHARMACEUTICALS INC (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31198 | Film No.: 121032989
SIC: 2834 Pharmaceutical Preparations